Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)
EIFFEL
Adipose Tissue Angiogenesis in Polycystic Ovary Syndrome (PCOS)
2 other identifiers
observational
36
1 country
1
Brief Summary
The purpose of this study is to collect data to help understand why some women develop Polycystic Ovary Syndrome (PCOS) associated with decreased lower-body fat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2012
CompletedStudy Start
First participant enrolled
December 6, 2012
CompletedFirst Posted
Study publicly available on registry
December 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 3, 2025
August 1, 2025
11.3 years
December 5, 2012
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference of angiogenesis capacity in abdominal and gluteal adipose tissue
The angiogenesis capacity of each adipose tissue depot will be determine by an in vitro angiogenesis test.
Day 7
Secondary Outcomes (2)
Presence of biomarkers in abdominal and gluteal adipose tissue in obese and PCOS women
Day 7
Difference in oxygen content of abdominal and gluteal adipose tissue
Day 6
Other Outcomes (2)
The rates of carbohydrate oxidation
Day -7
The rates of lipid oxidation
Day -7
Study Arms (3)
PCOS group
12 women with Polycystic Ovary Syndrome (PCOS) as defined by NIH criteria
Pear shapes
12 with an android pattern as defined by a waist-to-hip greater than 0.85
Apple shapes
12 will have a gynoid pattern as defined by a waist-to-hip ratio less than 0.78
Eligibility Criteria
Study Population and screening: Healthy young women with a BMI \> 30 will be recruited; 12 will have a gynoid pattern as defined by a waist-to-hip ratio less than 0.78 and 12 with an android pattern as defined by a waist-to-hip greater than 0.85. A third group will include 12 women with PCOS as defined by the NIH criteria. Subjects will be recruited via a dedicated website, physician referrals, direct mail outs, newspaper advertisements, and brochures. Only subjects that will sign informed consent and meet eligibility criteria will be enrolled in this study.
You may qualify if:
- Female
- Age \> 20 and \< 40
- Weight stable (change of less than 3 kg in the last 8 weeks)
- BMI \< 40 kg/m2 or \> 27 kg/m2
- NIH criteria - confirmed by subjects' medical records.
You may not qualify if:
- Male
- Women who are pregnant or lactating (breast feeding)
- Post-menopausal women
- Women with hysterectomy
- Diagnosed with diabetes, or have a fasting blood sugar \> 126 mg/dL.
- Untreated or symptomatic thyroid disease.
- Impaired kidney or liver function, as evidenced by your blood work
- Hypertension/ high blood pressure or are taking blood pressure medications
- Use of oral contraceptives or hormone replacement therapy.
- History of drug or alcohol abuse (\> 3 drinks per day) in the last 5 years, or psychiatric disease prohibiting adherence to study protocol.
- History of cancer within the last 5 years.
- History of organ transplant.
- History of HIV, active Hepatitis B or C, or Tuberculosis.
- History of heart attack/ myocardial infarction.
- Presence of clinically significant abnormalities on EKG.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AdventHealth Translational Research Institutelead
- Sanford-Burnham Medical Research Institutecollaborator
- Pennington Biomedical Research Centercollaborator
- Boston Universitycollaborator
- Tufts Universitycollaborator
Study Sites (1)
Translational Research Institute for Metabolism and Diabetes
Orlando, Florida, 32804, United States
Related Publications (47)
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005 Mar 24;352(12):1223-36. doi: 10.1056/NEJMra041536. No abstract available.
PMID: 15788499BACKGROUNDWeber RV, Buckley MC, Fried SK, Kral JG. Subcutaneous lipectomy causes a metabolic syndrome in hamsters. Am J Physiol Regul Integr Comp Physiol. 2000 Sep;279(3):R936-43. doi: 10.1152/ajpregu.2000.279.3.R936.
PMID: 10956251BACKGROUNDTran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 2008 May;7(5):410-20. doi: 10.1016/j.cmet.2008.04.004.
PMID: 18460332BACKGROUNDElbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ. Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab. 1997 Jul;82(7):2044-7. doi: 10.1210/jcem.82.7.4078.
PMID: 9215270BACKGROUNDElbers JM, Asscheman H, Seidell JC, Gooren LJ. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol. 1999 Feb;276(2):E317-25. doi: 10.1152/ajpendo.1999.276.2.E317.
PMID: 9950792BACKGROUNDShi H, Seeley RJ, Clegg DJ. Sexual differences in the control of energy homeostasis. Front Neuroendocrinol. 2009 Aug;30(3):396-404. doi: 10.1016/j.yfrne.2009.03.004. Epub 2009 Mar 31.
PMID: 19341761BACKGROUNDPerrot-Sinal TS. Do these genes make me look fat? Endocrinology. 2009 Mar;150(3):1075-7. doi: 10.1210/en.2008-1586. No abstract available.
PMID: 19240263BACKGROUNDLavebratt C, Almgren M, Ekstrom TJ. Epigenetic regulation in obesity. Int J Obes (Lond). 2012 Jun;36(6):757-65. doi: 10.1038/ijo.2011.178. Epub 2011 Sep 13.
PMID: 21912396BACKGROUNDWeisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003 Dec;112(12):1796-808. doi: 10.1172/JCI19246.
PMID: 14679176BACKGROUNDCinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005 Nov;46(11):2347-55. doi: 10.1194/jlr.M500294-JLR200. Epub 2005 Sep 8.
PMID: 16150820BACKGROUNDStrissel KJ, Stancheva Z, Miyoshi H, Perfield JW 2nd, DeFuria J, Jick Z, Greenberg AS, Obin MS. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007 Dec;56(12):2910-8. doi: 10.2337/db07-0767. Epub 2007 Sep 11.
PMID: 17848624BACKGROUNDRogers NH, Perfield JW 2nd, Strissel KJ, Obin MS, Greenberg AS. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology. 2009 May;150(5):2161-8. doi: 10.1210/en.2008-1405. Epub 2009 Jan 29.
PMID: 19179442BACKGROUNDGrove KL, Fried SK, Greenberg AS, Xiao XQ, Clegg DJ. A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int J Obes (Lond). 2010 Jun;34(6):989-1000. doi: 10.1038/ijo.2010.12. Epub 2010 Feb 16.
PMID: 20157318BACKGROUNDSparks LM, Ukropcova B, Smith J, Pasarica M, Hymel D, Xie H, Bray GA, Miles JM, Smith SR. Relation of adipose tissue to metabolic flexibility. Diabetes Res Clin Pract. 2009 Jan;83(1):32-43. doi: 10.1016/j.diabres.2008.09.052. Epub 2008 Nov 26.
PMID: 19038471BACKGROUNDHirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature. 2002 Nov 21;420(6913):333-6. doi: 10.1038/nature01137.
PMID: 12447443BACKGROUNDHotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8. doi: 10.1073/pnas.91.11.4854.
PMID: 8197147BACKGROUNDArkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005 Feb;11(2):191-8. doi: 10.1038/nm1185. Epub 2005 Jan 30.
PMID: 15685170BACKGROUNDMacotela Y, Boucher J, Tran TT, Kahn CR. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes. 2009 Apr;58(4):803-12. doi: 10.2337/db08-1054. Epub 2009 Jan 9.
PMID: 19136652BACKGROUNDGuerre-Millo M, Leturque A, Girard J, Lavau M. Increased insulin sensitivity and responsiveness of glucose metabolism in adipocytes from female versus male rats. J Clin Invest. 1985 Jul;76(1):109-16. doi: 10.1172/JCI111932.
PMID: 3894416BACKGROUNDD'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005 Oct 28;280(43):35983-91. doi: 10.1074/jbc.M507339200. Epub 2005 Aug 17.
PMID: 16109719BACKGROUNDRiant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009 May;150(5):2109-17. doi: 10.1210/en.2008-0971. Epub 2009 Jan 22.
PMID: 19164473BACKGROUNDGao H, Bryzgalova G, Hedman E, Khan A, Efendic S, Gustafsson JA, Dahlman-Wright K. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol. 2006 Jun;20(6):1287-99. doi: 10.1210/me.2006-0012. Epub 2006 Apr 20.
PMID: 16627594BACKGROUNDPasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009 Mar;58(3):718-25. doi: 10.2337/db08-1098. Epub 2008 Dec 15.
PMID: 19074987BACKGROUNDKhan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 2009 Mar;29(6):1575-91. doi: 10.1128/MCB.01300-08. Epub 2008 Dec 29.
PMID: 19114551BACKGROUNDHaas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R, Meyer MR, Amann K, Ammann E, Perez-Dominguez A, Genoni M, Clegg DJ, Dun NJ, Resta TC, Prossnitz ER, Barton M. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res. 2009 Feb 13;104(3):288-91. doi: 10.1161/CIRCRESAHA.108.190892. Epub 2009 Jan 29.
PMID: 19179659BACKGROUNDBelanger C, Luu-The V, Dupont P, Tchernof A. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm Metab Res. 2002 Nov-Dec;34(11-12):737-45. doi: 10.1055/s-2002-38265.
PMID: 12660892BACKGROUNDCleland WH, Mendelson CR, Simpson ER. Aromatase activity of membrane fractions of human adipose tissue stromal cells and adipocytes. Endocrinology. 1983 Dec;113(6):2155-60. doi: 10.1210/endo-113-6-2155.
PMID: 6641629BACKGROUNDBrasaemle DL, Dolios G, Shapiro L, Wang R. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J Biol Chem. 2004 Nov 5;279(45):46835-42. doi: 10.1074/jbc.M409340200. Epub 2004 Aug 27.
PMID: 15337753BACKGROUNDKhor VK, Tong MH, Qian Y, Song WC. Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse. Endocrinology. 2008 Nov;149(11):5440-8. doi: 10.1210/en.2008-0271. Epub 2008 Jul 31.
PMID: 18669602BACKGROUNDMarin P, Krotkiewski M, Bjorntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med. 1992 Oct;1(6):329-36.
PMID: 1341460BACKGROUNDLovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008 Jun;32(6):949-58. doi: 10.1038/ijo.2008.25. Epub 2008 Mar 11.
PMID: 18332882BACKGROUNDvan Nas A, Guhathakurta D, Wang SS, Yehya N, Horvath S, Zhang B, Ingram-Drake L, Chaudhuri G, Schadt EE, Drake TA, Arnold AP, Lusis AJ. Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. Endocrinology. 2009 Mar;150(3):1235-49. doi: 10.1210/en.2008-0563. Epub 2008 Oct 30.
PMID: 18974276BACKGROUNDGuo K, Mogen J, Struzzi S, Zhang Y. Preadipocyte transplantation: an in vivo study of direct leptin signaling on adipocyte morphogenesis and cell size. Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1339-47. doi: 10.1152/ajpregu.90691.2008. Epub 2009 Feb 4.
PMID: 19193947BACKGROUNDFabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351-79. doi: 10.1146/annurev-biochem-060308-103103.
PMID: 20533884BACKGROUNDJones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12735-40. doi: 10.1073/pnas.97.23.12735.
PMID: 11070087BACKGROUNDFriso S, Choi SW, Dolnikowski GG, Selhub J. A method to assess genomic DNA methylation using high-performance liquid chromatography/electrospray ionization mass spectrometry. Anal Chem. 2002 Sep 1;74(17):4526-31. doi: 10.1021/ac020050h.
PMID: 12236365BACKGROUNDElia M, Livesey G. Energy expenditure and fuel selection in biological systems: the theory and practice of calculations based on indirect calorimetry and tracer methods. World Rev Nutr Diet. 1992;70:68-131. doi: 10.1159/000421672. No abstract available.
PMID: 1292242BACKGROUNDFreda PU, Shen W, Reyes-Vidal CM, Geer EB, Arias-Mendoza F, Gallagher D, Heymsfield SB. Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry. J Clin Endocrinol Metab. 2009 Aug;94(8):2880-6. doi: 10.1210/jc.2009-0026. Epub 2009 Jun 2.
PMID: 19491226BACKGROUNDLivingstone MB, Black AE. Markers of the validity of reported energy intake. J Nutr. 2003 Mar;133 Suppl 3:895S-920S. doi: 10.1093/jn/133.3.895S.
PMID: 12612176BACKGROUNDSchoeller DA, Racette SB. A review of field techniques for the assessment of energy expenditure. J Nutr. 1990 Nov;120 Suppl 11(11 Suppl):1492-5. doi: 10.1093/jn/120.suppl_11.1492.
PMID: 2243294BACKGROUNDGealekman O, Guseva N, Hartigan C, Apotheker S, Gorgoglione M, Gurav K, Tran KV, Straubhaar J, Nicoloro S, Czech MP, Thompson M, Perugini RA, Corvera S. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation. 2011 Jan 18;123(2):186-94. doi: 10.1161/CIRCULATIONAHA.110.970145. Epub 2011 Jan 3.
PMID: 21200001BACKGROUNDLavau M, Susini C, Knittle J, Blanchet-Hirst S, Greenwood MR. A reliable photomicrographic method to determining fat cell size and number: application to dietary obesity. Proc Soc Exp Biol Med. 1977 Nov;156(2):251-6. doi: 10.3181/00379727-156-39916. No abstract available.
PMID: 928396BACKGROUNDAdams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, Schuler G, Hambrecht R. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):684-90. doi: 10.1161/01.ATV.0000124104.23702.a0. Epub 2004 Feb 26.
PMID: 14988094BACKGROUNDChironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, Rendu F, Simon A. Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis. 2007 Mar;191(1):115-20. doi: 10.1016/j.atherosclerosis.2006.02.041. Epub 2006 Apr 18.
PMID: 16620831BACKGROUNDVan Craenenbroeck EM, Conraads VM, Van Bockstaele DR, Haine SE, Vermeulen K, Van Tendeloo VF, Vrints CJ, Hoymans VY. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J Immunol Methods. 2008 Mar 20;332(1-2):31-40. doi: 10.1016/j.jim.2007.12.006. Epub 2008 Jan 18.
PMID: 18255093BACKGROUNDDivoux A, Sandor K, Bojcsuk D, Talukder A, Li X, Balint BL, Osborne TF, Smith SR. Differential open chromatin profile and transcriptomic signature define depot-specific human subcutaneous preadipocytes: primary outcomes. Clin Epigenetics. 2018 Nov 26;10(1):148. doi: 10.1186/s13148-018-0582-0.
PMID: 30477572DERIVEDDivoux A, Xie H, Li JL, Karastergiou K, Perera RJ, Chang RJ, Fried SK, Smith SR. MicroRNA-196 Regulates HOX Gene Expression in Human Gluteal Adipose Tissue. Obesity (Silver Spring). 2017 Aug;25(8):1375-1383. doi: 10.1002/oby.21896. Epub 2017 Jun 25.
PMID: 28649807DERIVED
Related Links
Biospecimen
Blood Urine Adipose tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adeline Divoux, PhD
Translational Research Institute for Metabolism and Diabetes
- PRINCIPAL INVESTIGATOR
Steven R Smith, MD
Translational Research Institute for Metabolism and Diabetes
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2012
First Posted
December 10, 2012
Study Start
December 6, 2012
Primary Completion
April 4, 2024
Study Completion
December 1, 2025
Last Updated
August 3, 2025
Record last verified: 2025-08